InvestorsHub Logo

Johnny_C

09/12/17 10:10 PM

#417 RE: agamemnus #414

50 is not enough, the bigger point is they have zero track record and are starting from scratch with a product nobody seems to want.

big pharma buys private companies all day long, if the product was a 500 mil a year cash cow big pharma would have bought in a heartbeat. they are using cemp money to try to market this....bullskit.